The Clearance and Biodistribution of Magnetic Composite Nanoparticles in Healthy and Osteoarthritic Rat Knees

Overview

Journal J Control Release

Specialty Pharmacology

Date 2020 Feb 1

PMID 32004585

Citations 13

Authors

Brittany D Partain

Mythreyi Unni

Carlos Rinaldi

Kyle D Allen

Affiliations

Soon will be listed here.

Abstract

Intra-articular injections are the most direct route for administering osteoarthritis (OA) therapies, yet how drug carriers distribute within the joint remains understudied. To this end, we developed a magnetic composite nanoparticle that can be tracked with fluorescence in vivo via an in vivo imaging system (IVIS), and quantified ex vivo via electron paramagnetic resonance (EPR) spectroscopy. Using this particle, the effects of age and OA pathogenesis on particle clearance and distribution were evaluated in the medial meniscus transection model of OA (5-, 10-, and 15-month old male Lewis rats). At 9 weeks after meniscus transection, composite nanoparticles were injected and joint clearance was assessed via IVIS. At 2 weeks after injection, animals were euthanized and particle distribution was quantified ex vivo via EPR spectroscopy. IVIS and EPR spectroscopy data indicate a predominant amount of particles remained in the joint after 14 days. EPR spectroscopy data suggests particles cleared more slowly from OA knees than from the contralateral control, with particles clearing more slowly from 15-month old rats than from 5- and 10-month old rats. This study demonstrates the importance of including both age and OA as factors when evaluating nanoparticles for intra-articular drug delivery.

Citing Articles

Innovative Biotherapies and Nanotechnology in Osteoarthritis: Advancements in Inflammation Control and Cartilage Regeneration.

Liu B, Liu T, Li Y, Tan C Int J Mol Sci. 2025; 25(24.

PMID: 39769149 PMC: 11677281. DOI: 10.3390/ijms252413384.

Advancing osteoarthritis therapy with GMOCS hydrogel-loaded BMSCs-exos.

Zhou R, Guo J, Jin Z J Nanobiotechnology. 2024; 22(1):493.

PMID: 39160590 PMC: 11334447. DOI: 10.1186/s12951-024-02713-z.

Preparation of Melatonin-Loaded Nanoparticles with Targeting and Sustained Release Function and Their Application in Osteoarthritis.

Liang H, Yan Y, Sun W, Ma X, Su Z, Liu Z Int J Mol Sci. 2023; 24(10).

PMID: 37240086 PMC: 10217911. DOI: 10.3390/ijms24108740.

Application of magnetic particle imaging to evaluate nanoparticle fate in rodent joints.

Ajayi T, Liu S, Rosen C, Rinaldi-Ramos C, Allen K, Sharma B J Control Release. 2023; 356:347-359.

PMID: 36868518 PMC: 11565467. DOI: 10.1016/j.jconrel.2023.02.038.

Intra-articular kinetics of a cartilage targeting cationic PEGylated protein for applications in drug delivery.

He T, Zhang C, Colombani T, Bencherif S, Porter R, Bajpayee A Osteoarthritis Cartilage. 2022; 31(2):187-198.

PMID: 36241136 PMC: 9892226. DOI: 10.1016/j.joca.2022.09.010.

References

Bajpayee A, Scheu M, Grodzinsky A, Porter R . Electrostatic interactions enable rapid penetration, enhanced uptake and retention of intra-articular injected avidin in rat knee joints. J Orthop Res. 2014; 32(8):1044-51. DOI: 10.1002/jor.22630. View

Moore Jr J, Bertram C . Lymphatic System Flows. Annu Rev Fluid Mech. 2018; 50:459-482. PMC: 5922450. DOI: 10.1146/annurev-fluid-122316-045259. View

Seifer D, Furman B, Guilak F, Olson S, Brooks 3rd S, Kraus V . Novel synovial fluid recovery method allows for quantification of a marker of arthritis in mice. Osteoarthritis Cartilage. 2008; 16(12):1532-8. PMC: 2602808. DOI: 10.1016/j.joca.2008.04.013. View

Singh A, Agarwal R, Diaz-Ruiz C, Willett N, Wang P, Lee L . Nanoengineered particles for enhanced intra-articular retention and delivery of proteins. Adv Healthc Mater. 2014; 3(10):1562-7, 1525. PMC: 4182168. DOI: 10.1002/adhm.201400051. View

Rothenfluh D, Bermudez H, ONeil C, Hubbell J . Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage. Nat Mater. 2008; 7(3):248-54. DOI: 10.1038/nmat2116. View

Hootman J, Helmick C, Barbour K, Theis K, Boring M . Updated Projected Prevalence of Self-Reported Doctor-Diagnosed Arthritis and Arthritis-Attributable Activity Limitation Among US Adults, 2015-2040. Arthritis Rheumatol. 2016; 68(7):1582-7. PMC: 6059375. DOI: 10.1002/art.39692. View

Hootman J, Helmick C . Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 2005; 54(1):226-9. DOI: 10.1002/art.21562. View

Larsen N, Dursema H, Pollak C, Skrabut E . Clearance kinetics of a hylan-based viscosupplement after intra-articular and intravenous administration in animal models. J Biomed Mater Res B Appl Biomater. 2011; 100(2):457-62. DOI: 10.1002/jbm.b.31971. View

Zolla V, Nizamutdinova I, Scharf B, Clement C, Maejima D, Akl T . Aging-related anatomical and biochemical changes in lymphatic collectors impair lymph transport, fluid homeostasis, and pathogen clearance. Aging Cell. 2015; 14(4):582-94. PMC: 4531072. DOI: 10.1111/acel.12330. View

10.

Morgen M, Tung D, Boras B, Miller W, Malfait A, Tortorella M . Nanoparticles for improved local retention after intra-articular injection into the knee joint. Pharm Res. 2012; 30(1):257-68. PMC: 3524502. DOI: 10.1007/s11095-012-0870-x. View

11.

Hu H, Lim N, Ding-Pfennigdorff D, Saas J, Wendt K, Ritzeler O . DOTAM derivatives as active cartilage-targeting drug carriers for the treatment of osteoarthritis. Bioconjug Chem. 2015; 26(3):383-8. DOI: 10.1021/bc500557s. View

12.

Kang M, Kim J, Im G . Thermoresponsive nanospheres with independent dual drug release profiles for the treatment of osteoarthritis. Acta Biomater. 2016; 39:65-78. DOI: 10.1016/j.actbio.2016.05.005. View

13.

Chertok B, Cole A, David A, Yang V . Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Mol Pharm. 2009; 7(2):375-85. PMC: 2849878. DOI: 10.1021/mp900161h. View

14.

Zhang W, Moskowitz R, Nuki G, Abramson S, Altman R, Arden N . OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage. 2008; 16(2):137-62. DOI: 10.1016/j.joca.2007.12.013. View

15.

Thakkar H, Sharma R, Mishra A, Chuttani K, Murthy R . Celecoxib incorporated chitosan microspheres: in vitro and in vivo evaluation. J Drug Target. 2004; 12(9-10):549-57. DOI: 10.1080/10611860400010630. View

16.

Danhier P, De Preter G, Magat J, Godechal Q, Porporato P, Jordan B . Multimodal cell tracking of a spontaneous metastasis model: comparison between MRI, electron paramagnetic resonance and bioluminescence. Contrast Media Mol Imaging. 2014; 9(2):143-53. DOI: 10.1002/cmmi.1553. View

17.

Vangijzegem T, Stanicki D, Laurent S . Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics. Expert Opin Drug Deliv. 2018; 16(1):69-78. DOI: 10.1080/17425247.2019.1554647. View

18.

Owen S, Francis H, Roberts M . Disappearance kinetics of solutes from synovial fluid after intra-articular injection. Br J Clin Pharmacol. 1994; 38(4):349-55. PMC: 1364779. DOI: 10.1111/j.1365-2125.1994.tb04365.x. View

19.

Brown S, Kumar S, Sharma B . Intra-articular targeting of nanomaterials for the treatment of osteoarthritis. Acta Biomater. 2019; 93:239-257. PMC: 6615949. DOI: 10.1016/j.actbio.2019.03.010. View

20.

Kushner I, Somerville J . Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis Rheum. 1971; 14(5):560-70. DOI: 10.1002/art.1780140503. View